Pulmocide pulmocide.com


Pulmocide is a biotechnology firm developing novel small molecule inhaled medicines for the treatment of life threatening respiratory infections caused by RSV and Aspergillus.

Pulmocide is a biotechnology firm developing novel small molecule inhaled medicines for the treatment of life threatening respiratory infections caused by RSV and Aspergillus.

Company (Alive / Active)

Phone: +44 203 763 9484

Fax:

52 Princes Gate
Exhibition Road, South Kensington
London, SW7 2BP
England, United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Pulmocide $57.8M Mar 20, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Pulmocide Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Compounds useful to treat mycoses Nov 09, 2016 May 15, 2018 Patent
5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivative Jul 06, 2017 Mar 27, 2018 Patent
5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivative Oct 08, 2015 Aug 15, 2017 Patent
Novel 5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivatives Dec 18, 2015 Application
Novel 5,6-dihydro-4h-benzo[b]thieno-[2,3-d]azepine derivatives Oct 08, 2015 Application